New Zealand

Sarah is a formulation scientist based in Aotearoa New Zealand, specialising in RNA delivery and lipid nanoparticle (LNP) development. She leads RNA formulation at the manufacturing facility of the national RNA Development Platform and focuses on creating practical, scalable LNP systems for vaccines and therapeutics. Sarah is passionate about building New Zealand’s RNA capability and translating research into real-world impact. Sarah is the New Zealand representative on the A-RNA EMCR committee.